Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gilead Viread Virology Data Will Distinguish HIV Drug In Physician Promotions

Nov 05 2001

• By The Pink Sheet

Related Content

Viread Pediatric Trials May Proceed Despite Bone Toxicity Potential - FDA

Oct 08 2001

Gilead Viread Use Beyond HIV Drug-Experienced Patients Questioned By Cmte

Oct 08 2001

Gilead Adefovir Approval Awaits "Unequivocal" Evidence Of Efficacy At 60 mg

Nov 08 1999

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window